Business, Energy and Industrial Strategy Committee
Debate between Rachel Reeves and Paula Sherriff
Rachel Reeves
The idea that leaving the European Union is about cutting red tape is absolutely ridiculous. In fact, red tape protects us, and in pharmaceuticals that is absolutely crucial. As for the EMA and the MHRA, we will be replicating something that worked incredibly well. Why create a load of new regulators when we had a set of regulators based here in the UK doing a fantastic job? No one doubts that the EMA was doing a good job, so why replicate it now? It makes no sense.
Paula Sherriff (Dewsbury) (Lab)
I am sure many Members will concur that British businesses, including those in the pharma sector, desperately need some certainty. Does my hon. Friend agree that the Government should stop fighting themselves, and should start to make decisions that are in the best interests of the UK?
Rachel Reeves
I absolutely agree. The Government need to get on with negotiating with the European Union, rather than negotiating with their Back Benchers and even within the Cabinet. We need certainty. We need certainty on our access to the single market, we need certainty on our membership of the customs union, and we need certainty on the regulatory framework that will apply after we leave the European Union. Without that, it is incredibly difficult for businesses to plan for the future, to secure the jobs and investment that we need in this country, and, in the case of medicines and pharmaceuticals, to ensure that patients have access—timely access—to the best drugs, and new drugs.